Literature DB >> 14565129

[Epidemiological pattern of scarlet fever in recent years].

N I Briko1, N N Filatov, M V Zhuravlev, I N Lytkina, E B Ezhlova, A Iu Brazhnikov, N N Tsapkova, N A Malyshev.   

Abstract

During the period of 1953-2001 scarlet fever morbidity level fluctuated from 670.3 to 65.9 per 100,000 of the population in Moscow and from 531.9 to 35.0 per 100,000 of the population of the Russian Federation. In recent years an increased morbidity was more pronounced in Moscow than in the Russian Federation as a whole. Children formed the greater part of scarlet fever patients, the cases of scarlet fever among children in Moscow occurring more often than, on the average, in Russia. As before, annual morbidity among children attending children's institutions was higher 3- to 4-fold than among children brought up at home. This difference was most sharply pronounced among young children during the first two years of their life. In contrast to morbidity observed during previous 20-30 years, a drop in morbidity among children during the first two years of their life was registered, while morbidity level among children aged 3-6 years and 7-14 years increased. Scarlet fever morbidity had a pronounced seasonal (autumn-winter) pattern. In a group of children aged 3-5 years who attended organized groups, on the average, 78.6% of scarlet fever cases fell on seasonal morbidity, the most prolonged one.

Entities:  

Mesh:

Year:  2003        PMID: 14565129

Source DB:  PubMed          Journal:  Zh Mikrobiol Epidemiol Immunobiol        ISSN: 0372-9311


  2 in total

1.  Impact of meteorological changes on the incidence of scarlet fever in Hefei City, China.

Authors:  Yu Duan; Xiao-Lei Huang; Yu-Jie Wang; Jun-Qing Zhang; Qi Zhang; Yue-Wen Dang; Jing Wang
Journal:  Int J Biometeorol       Date:  2016-03-01       Impact factor: 3.787

2.  Spectral analysis based on fast Fourier transformation (FFT) of surveillance data: the case of scarlet fever in China.

Authors:  T Zhang; M Yang; X Xiao; Z Feng; C Li; Z Zhou; Q Ren; X Li
Journal:  Epidemiol Infect       Date:  2013-06-10       Impact factor: 4.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.